TauRx Pharmaceuticals' experimental Alzheimer's drug LMTX failed to improve cognitive and functional skills in patients with mild to moderate Alzheimer's disease.
- Celgene Snaps Up Merck & Co.’s Giant Complex in New Jersey 7,500 views
- Top 10 Pipelines 5,766 views
- Annual Report: Top 10 Pipelines 4,700 views
- Top 100 Biotechnology Companies Special Report: The Acquisition Game 2,700 views